Martin Austin
Non-Executive Director; RSA AG

Martin Austin is Managing Director of TransformRx GmbH, which he formed in 2005 to provide business advice to clients regarding investment and business development. He is also a Partner in MarraM Conseils SA, an Investment Governance company, and Chairman of RSA AG, the Swiss subsidiary of RSA.

He was previously a Principal in the Paul Capital Partners Royalty Funds, a USA-based specialist in Secondary Private Equity and Alternative Asset Investments and before that as Head of Business Development for the Pharmaceuticals Division at F. Hoffmann-La Roche.

Martin has had a broad ranging career in the Pharmaceutical industry, starting as a Medical Representative in 1977. Progressing through Sales and Marketing roles with GD Searle in the early 1980's he went on to become Business Development Manager with Lorex Pharmaceuticals and then a consultant with Marketing Improvements before leaving to become a founding Director of Machine Intelligence Technologies. Later, he took over Business Development for the Dendrite organisation before being appointed Managing Director of MHIG Ltd, an international joint venture in Market Research and consulting, prior to joining Roche.